IGF-1 LR3 - Peptide Match
PEPTIDE

IGF-1 LR3

IGF-1 LR3 is an investigational compound studied for its potential to support muscle growth and tissue repair.

Glass vial with red cap and label used for medication or vaccine storage

Quick facts

Red check mark icon inside a circle indicating success or confirmation
FDA Status

Research Use Only

Red check mark icon inside a circle indicating success or confirmation
Research

Pre-Clinical

What is IGF-1 LR3?

IGF-1 LR3 is an investigational compound based on insulin-like growth factor 1 (IGF-1). It has been changed in the lab so it can avoid the proteins that normally stop natural IGF-1 from reaching tissues. Because it can bypass these roadblocks, researchers are studying how it might activate pathways for muscle growth, tissue repair, and cellular energy in preclinical models.

Tesamorelin

Common Uses

management
Body composition

Research suggests IGF-1 LR3 acts on cellular receptors to support muscle protein synthesis and lean mass development in preclinical models.

recovery icon
Muscle recovery

Preclinical research indicates IGF-1 LR3 may support recovery from physical stress through its effects on cellular repair pathways.

life icon
Tissue repair

Research suggests IGF-1 LR3 acts on cellular pathways to support tissue repair and regeneration.

ion_medical-outline-icon
Muscle preservation

Preclinical research indicates IGF-1 LR3 may help prevent muscle breakdown by activating protein synthesis pathways.

Studies & Clinical Research

Most growth factor peptides get neutralized by binding proteins before they can reach tissues. IGF-1 LR3 was engineered to slip

Read More IGF-1 LR3: The Growth Factor Peptide Built to Stay in the Body Longer Read More Arrow Icon
FAQ

You have questions.
We have answers.

Have a question you don’t see answered?

What does IGF-1 LR3 do?
FAQ Icon

IGF-1 LR3 is an investigational compound designed to reach tissues more effectively than natural IGF-1. In preclinical research, IGF-1 LR3 was associated with activating cellular pathways for muscle growth, protein synthesis, and tissue repair.

Is it safe?
FAQ Icon

IGF-1 LR3 is an investigational compound and is not FDA-approved. It lacks large-scale human safety trials, and its safety profile in humans is not fully known. A licensed healthcare provider should be consulted before use.

How long does it take to work?
FAQ Icon

Human data on the timeline for IGF-1 LR3 effects is very limited, as most research has been conducted in preclinical models. Because it is an investigational compound, meaningful timelines for human use have not been established.

Do I need a provider?
FAQ Icon

Yes. IGF-1 LR3 is not FDA-approved and is an investigational compound. A licensed healthcare provider should review your health history before you consider IGF-1 LR3.

Have a question you don’t see answered?

Ready to take the next step?

Find a verified peptide therapy provider or list your practice and connect with patients actively seeking trusted care.